|
|
 |
Publications
Displaying 481 through 500 of 1537 items.
« Previous
Page
1 10 20 21 22 23 24
25
26 27 28 29 30 40 50 60 70 77
Next »
[Show All]
| 2009 |
Jeuland, M., J. Cook, C. Poulos, J. Clemens, and D. Whittington. (2009). "Cost-effectiveness of new-generation oral cholera vaccines: A multisite analysis." Value in Health, 12(6):899-908.
Objectives: We evaluated the cost-effectiveness of a low-cost cholera vaccine licensed and used in Vietnam, using recently collected data from four developing countries where cholera is endemic. Our...
Full Abstract »
|
Candrilli, S.D., R. Balkrishnan, and S.H. O'Brien. (2009). "Effect of injury severity on the incidence and utilization-related outcomes of venous thromboembolism in pediatric trauma inpatients." Pediatric Critical Care Medicine, 10(5):554-557.
|
Lanza, L.L., L. Wang, T.A. Simon, and W.D. Irish. (2009). "Epidemiologic critique of literature on post-transplant neoplasms in solid organ transplantation." Clinical Transplantation, 23(5):582-588.
As survival of transplant recipients improves, long-term complications become more important. We reviewed epidemiologic literature on real-world risks of de novo neoplasia post-transplant. We...
Full Abstract »
|
Bradbury, B.D., M.A. Brookhart, W.C. Winkelmayer, C.W. Critchlow, R.D. Kilpatrick, M.M. Joffe, H.I. Feldman, J.F. Acquavella, O.H. Wang, and K.J. Rothman. (2009). "Evolving Statistical Methods to Facilitate Evaluation of the Causal Association Between Erythropoiesis-Stimulating Agent Dose and Mortality in Nonexperimental Research: Strengths and Limitations." American Journal of Kidney Diseases, 54(3):554-560.
|
Norgaard, M., V. Ehrenstein, B.E. Mahon, G.L. Nielsen, K.J. Rothman, and H.T. Sorensen. (2009). "Febrile Seizures and Cognitive Function in Young Adult Life: A Prevalence Study in Danish Conscripts." Journal of Pediatrics, 155(3):404-409.
|
Rothman, K.J.. (2009). "Health effects of mobile telephones." Epidemiology, 20(5):653-655.
The safety of mobile telephones is a pressing question, now that the brains of nearly half the humans on the planet have become exposed within a short span of time to a physical agent to which their...
Full Abstract »
|
Gramling, R., C.B. Eaton, K.J. Rothman, H. Cabral, R.A. Silliman, and T.L. Lash. (2009). "Hormone Replacement Therapy, Family History, and Breast Cancer Risk Among Postmenopausal Women." Epidemiology, 20(5):752-756.
|
Candrilli, S.D., K.L. Davis, and S. Iyer. (2009). "Impact of constipation on opioid use patterns, health care resource utilization, and costs in cancer patients on opioid therapy." Journal of Pain & Palliative Care Pharmacotherapy, 23(3):231-241.
Patterns of opioid use, resource utilization, and costs in cancer patients with and without constipation were compared using retrospective insurance claims data. Inclusion criteria were > =30 days...
Full Abstract »
|
Pattanayak, S.K., C. Poulos, J.C. Yang, S.R. Patil, and K.J. Wendland. (2009). "Of taps and toilets: Quasi-experimental protocol for evaluating community-demand-driven projects." Journal of Water and Health, 7(3):434-451.
Sustainable and equitable access to safe water and adequate sanitation are widely acknowledged as vital, yet neglected, development goals. Water supply and sanitation (WSS) policies are justified...
Full Abstract »
|
Mikkelsen, E.M., E.E. Hatch, L.A. Wise, K.J. Rothman, A. Riis, and H.T. Sorensen. (2009). "Cohort Profile: The Danish Web-based Pregnancy Planning StudySnart-Gravid." International Journal of Epidemiology, 38(4):938-943.
|
Pattanayak, S.K., J.C. Yang, K.L. Dickinson, C. Poulos, S.R. Patil, R.K. Mallick, J.L. Blitstein, and P. Praharaj. (2009). "Shame or subsidy revisited: Social mobilization for sanitation in Orissa, India." Bulletin of the World Health Organization, 87(8):580-587.
OBJECTIVE: To determine the effectiveness of a sanitation campaign that combines “shaming” (i.e. emotional motivators) with subsidies for poor households in rural Orissa, an Indian state with a...
Full Abstract »
|
Martin, S., A. Chandran, L. Zografos, and G. Zlateva. (2009). "Evaluation of the impact of fibromyalgia on patients' sleep and the content validity of two sleep scales." Health and Quality of Life Outcomes, 7:64-.
BACKGROUND: Disturbed sleep is commonly reported in fibromyalgia (FM). Both the Sleep Quality Numeric Rating Scale (NRS) and the Medical Outcomes Study Sleep Scale (MOS-Sleep) have demonstrated...
Full Abstract »
|
Ozdemir, S., F.R. Johnson, and A.B. Hauber. (2009). "Hypothetical bias, cheap talk, and stated willingness to pay for health care." Journal of Health Economics, 28(4):894-901.
Subjects with rheumatoid arthritis (RA) enrolled in an online panel were asked to evaluate pairs of treatment alternatives with different attributes. Half of the sample saw a cheap-talk text....
Full Abstract »
|
Arbuckle, R., M. Clark, J. Harness, N. Bonner, J. Scott, Z. Draelos, R. Rizer, Y. Yeh, and K. Copley-Merriman. (2009). "Item Reduction and Psychometric Validation of the Oily Skin Self Assessment Scale (OSSAS) and the Oily Skin Impact Scale (OSIS)." Value in Health, 12(5):828-837.
|
Andrews, E.B., J.A. Kaye, and C. Van Bennekom. (2009). "The REMS publication paradox." Oncology (Williston Park, N.Y.), 23(8):715-717.
|
Rosen, R.C., J.L. Shifren, B.U. Monz, D.M. Odom, P.A. Russo, and C.B. Johannes. (2009). "Correlates of Sexually Related Personal Distress in Women with Low Sexual Desire." Journal of Sexual Medicine, 6(6):1549-1560.
|
Earnshaw, S.R., J. Graham, M. Oleen-Burkey, J. Castelli-Haley, and K. Johnson. (2009). "Cost Effectiveness of Glatiramer Acetate and Natalizumab in Relapsing-Remitting Multiple Sclerosis." Applied Health Economics and Health Policy, 7(2):91-108.
Disease-modifying drugs are a significant expenditure for treating multiple sclerosis. Natalizumab (NZ) has been shown to be effective in reducing relapses and disease progression. However,...
Full Abstract »
|
Earnshaw, S.R., J. Graham, M.K. Oleen-Burkey, J. Castelli-Haley, and K. Johnson. (2009). "Cost effectiveness of glatiramer acetate and natalizumab in relapsing-remitting multiple sclerosis." Applied Health Economics and Health Policy, 7(2):91-108.
Background: Disease-modifying drugs are a significant expenditure for treating multiple sclerosis. Natalizumab (NZ) has been shown to be effective in reducing relapses and disease progression....
Full Abstract »
|
Evans, W.D., J. Uhrig, K. Davis, and L. McCormack. (2009). "Efficacy Methods to Evaluate Health Communication and Marketing Campaigns." Journal of Health Communication, 14(4):315-330.
Communication and marketing are growing areas of health research, but relatively few rigorous efficacy studies have been conducted in these fields. In this article, we review recent health...
Full Abstract »
|
Hauber, A.B.. (2009). "Healthy-years equivalent: Wounded but not yet dead." Expert Review of Pharmacoeconomics & Outcomes Research, 9(3):265-269.
The quality-adjusted life-year (QALY) has become the dominant measure of health value in health technology assessment in recent decades despite some well-known and fundamental flaws in the...
Full Abstract »
|
Displaying 481 through 500 of 1537 items.
« Previous
Page
1 10 20 21 22 23 24
25
26 27 28 29 30 40 50 60 70 77
Next »
[Show All]
|